Autosomal Dominant Non-Syndromic Hearing Loss

$510,986R01FY2013DCNIH

University Of Iowa, Iowa City IA

Investigators

Linked publications & trials

Paper 34592158 Paper 33398081 Paper 32917668 Paper 32579737 Paper 32277154 Paper 30865901 Paper 30686588 Paper 30464345 Paper 30249598 Paper 30245514 Paper 30245029 Paper 30242206 Paper 30241496 Paper 29765956 Paper 29703829 Paper 29530094 Paper 29445157 Paper 29293958 Paper 29266521 Paper 29112224 Paper 29084757 Paper 28570415 Paper 28383465 Paper 28213135 Paper 28181545 Paper 28079113 Paper 27743438 Paper 27552069 Paper 27469136 Paper 27246798 Paper 27236922 Paper 27096712 Paper 26969326 Paper 26530094 Paper 26469318 Paper 26445815 Paper 26416264 Paper 26346818 Paper 26216887 Paper 26084827 Paper 25986071 Paper 25816005 Paper 25792669 Paper 25792666 Paper 25788564 Paper 25788561 Paper 25743181 Paper 25491636 Paper 25262649 Paper 25123904 Paper 24963352 Paper 24729539 Paper 24492129 Paper 23851940 Paper 23804846 Paper 23280582 Paper 23148716 Paper 23042251 Paper 22975204 Paper 22785243 Paper 22559009 Paper 22016077 Paper 21910243 Paper 21841894 Paper 21530627 Paper 21520338 Paper 21484990 Paper 21368133 Paper 21081075 Paper 21078986 Paper 21046548 Paper 20648059 Paper 20447146 Paper 20186779 Paper 19780026 Paper 19601806 Paper 19494570 Paper 19486694 Paper 19274735 Paper 19215054 Paper 19161137 Paper 18941426 Paper 18804553 Paper 18688868 Paper 18674745 Paper 18220287 Paper 17666886 Paper 17661817 Paper 17568404 Paper 17494702 Paper 17462767 Paper 17427029 Paper 17372079 Paper 17238186 Paper 16365218 Paper 16282775 Paper 16222661 Paper 15857852 Paper 15752533 Paper 15492887

Abstract

DESCRIPTION (provided by applicant): Hearing loss affects 15-26% of the world's population and among the elderly is the most common neurological disability. Although the relative contributions of hereditary and environmental factors to age- related hearing loss are unknown, the majority of inherited late-onset deafness is autosomal dominant and non-syndromic (autosomal dominant non-syndromic hearing loss, ADNSHL). The long-term goals of our research are: a) to identify ADNSHL-causing genes to address gaps in our understanding of the molecular biology of hearing and deafness in the elderly; and, b) to explore novel habilitation options for hearing loss. During the prior granting period, we focused on specific aims to: 1) localize and clone genes that cause ADNSHL; 2) expand phenotype-genotype studies to facilitate gene identification in small families; and 3) initiate experiments on RNA interference (RNAi) as a potential treatment for select types of hearing loss. In this competitive renewal, we will build on our past accomplishments by completing the following specific aims: Specific Aim 1: To identify novel deafness-causing genes in a cohort of 230 families segregating ADNSHL by using targeted sequence capture platforms and/or whole exome analysis followed by massively parallel sequencing and data analysis using a customized local deployment of the Galaxy bioinformatics web platform Specific Aim 2: To improve and validate the efficacy of RNAi as a therapeutic for the prevention of ADNSHL by: a) modifying the design of short hairpin RNA (shRNA) and artificial microRNA (miRNA) to enhance their potency in the Kcnq4+/dn mouse; and, b) testing RNAi in a second murine model of ADNSHL, the Tmc1 G411R mutant mouse The successful completion of these aims will have a major impact on our understanding of the biology of hearing and deafness and potentially on the treatment of some types of hearing loss.

View original record on NIH RePORTER →